Effects of a Classic High-frequency rTMS Treatment Versus a Deep rTMS Treatment (HAUVERDEEP)
Primary Purpose
Depressive Disorder, Treatment-Resistant
Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
classic rTMS using the 8-shaped coil
deep rTMS using the H1-shaped coil
Sponsored by
About this trial
This is an interventional treatment trial for Depressive Disorder, Treatment-Resistant
Eligibility Criteria
Inclusion Criteria:
- Volunteer subjects over 18 years old
- Having signed a free and informed consent
- Having a diagnostic of caracterised depressive episod recurrent or isolated according to DSM IV criteria (A.P.A 1994).
- Having an antidepressant treatment not modified since 3 weeks
- Score to MADRS scale ≥ 21
- Subject affiliated to a social security regimen
Exclusion Criteria:
- Depression with psychotic caracteristics
- Co-morbid diagnosis according to axis I (DSM IV) of schizophrenia, dependence (or abuse) on alcohol and / or another substance (lifetime)
- Patient who has already undergone seismotherapy for current episode and non-responder to this treatment
- Patient hospitalized under duress or under legal protection (guardianship, curatorship)
- Patient with a high risk of suicide (item 10 of MADRS > 4) in the absence of hospitalization.
- Contra-indication for IRM exam or rTMS : personnal history of comitial crisis, of neurological or neurochirurgical pathologies, metallic prosthetic material or foreign body (pacemaker, intraoculare ferromagnetic material, implanted cardiac defibrillator, cochlear implant, metal clip
- Pregnancy
- Simultaneous participation to another interventionnal study
Sites / Locations
- Centre Hospitalier Henri LaboritRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
classic rTMS treatment
treatment with deep rTMS
Arm Description
Arm A: classic rTMS treatment (use of the 8-shaped coil) and standard therapy
Arm B: treatment with deep rTMS (use of the H1-shaped coil (helmet)) and standard therapies
Outcomes
Primary Outcome Measures
A 50% change of MADRS score
The main objective is to demonstrate that dTMS is more efficient than high frequency rTMS with a conventional coil.
Modification of the MADRS score compared to baseline score. MADRS stands for Montgomery-Asberg Depression Rating Scale. It is used to measure the severity of depressive episodes in patients with mood disorders. The questionnaire includes questions on the following symptoms 1. Apparent sadness 2. Reported sadness 3. Inner tension 4. Reduced sleep 5. Reduced appetite 6. Concentration difficulties 7. Lassitude 8. Inability to feel 9. Pessimistic thoughts 10. Suicidal thoughts and each item yields a score of 0 to 6. The overall score ranges from 0 to 60. A score from 0 to 6 being normal/symptom absent and a score >34 being severe depression.
Secondary Outcome Measures
Full Information
NCT ID
NCT04956016
First Posted
June 29, 2021
Last Updated
January 18, 2023
Sponsor
Centre Hospitalier Henri Laborit
1. Study Identification
Unique Protocol Identification Number
NCT04956016
Brief Title
Effects of a Classic High-frequency rTMS Treatment Versus a Deep rTMS Treatment
Acronym
HAUVERDEEP
Official Title
Open-label Randomized Comparative Study of the Effects of a Classic High-frequency rTMS Treatment Versus a Deep rTMS Treatment in the Management of Resistant Depression
Study Type
Interventional
2. Study Status
Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 23, 2021 (Actual)
Primary Completion Date
November 2024 (Anticipated)
Study Completion Date
November 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Henri Laborit
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The main objective is to demonstrate that dTMS is more efficient than high frequency rTMS with a conventional coil.
The patient will receive treatment arm A or B :
Arm A : classic rTMS treatment (use of the 8-shaped coil) and standard therapy Arm B: treatment with deep rTMS (use of the H-shaped coil (helmet)) and standard therapies.
20 rTMS sessions are planned (5 sessions per week) and 3 follow-up visits : at Day 30, Day 60 and Day 90.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depressive Disorder, Treatment-Resistant
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
152 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
classic rTMS treatment
Arm Type
Active Comparator
Arm Description
Arm A: classic rTMS treatment (use of the 8-shaped coil) and standard therapy
Arm Title
treatment with deep rTMS
Arm Type
Active Comparator
Arm Description
Arm B: treatment with deep rTMS (use of the H1-shaped coil (helmet)) and standard therapies
Intervention Type
Device
Intervention Name(s)
classic rTMS using the 8-shaped coil
Intervention Description
20 rTMS sessions are planned (5 sessions per week)
Intervention Type
Device
Intervention Name(s)
deep rTMS using the H1-shaped coil
Intervention Description
20 rTMS sessions are planned (5 sessions per week)
Primary Outcome Measure Information:
Title
A 50% change of MADRS score
Description
The main objective is to demonstrate that dTMS is more efficient than high frequency rTMS with a conventional coil.
Modification of the MADRS score compared to baseline score. MADRS stands for Montgomery-Asberg Depression Rating Scale. It is used to measure the severity of depressive episodes in patients with mood disorders. The questionnaire includes questions on the following symptoms 1. Apparent sadness 2. Reported sadness 3. Inner tension 4. Reduced sleep 5. Reduced appetite 6. Concentration difficulties 7. Lassitude 8. Inability to feel 9. Pessimistic thoughts 10. Suicidal thoughts and each item yields a score of 0 to 6. The overall score ranges from 0 to 60. A score from 0 to 6 being normal/symptom absent and a score >34 being severe depression.
Time Frame
Day 60
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Volunteer subjects over 18 years old
Having signed a free and informed consent
Having a diagnostic of caracterised depressive episod recurrent or isolated according to DSM IV criteria (A.P.A 1994).
Having an antidepressant treatment not modified since 3 weeks
Score to MADRS scale ≥ 21
Subject affiliated to a social security regimen
Exclusion Criteria:
Depression with psychotic caracteristics
Co-morbid diagnosis according to axis I (DSM IV) of schizophrenia, dependence (or abuse) on alcohol and / or another substance (lifetime)
Patient who has already undergone seismotherapy for current episode and non-responder to this treatment
Patient hospitalized under duress or under legal protection (guardianship, curatorship)
Patient with a high risk of suicide (item 10 of MADRS > 4) in the absence of hospitalization.
Contra-indication for IRM exam or rTMS : personnal history of comitial crisis, of neurological or neurochirurgical pathologies, metallic prosthetic material or foreign body (pacemaker, intraoculare ferromagnetic material, implanted cardiac defibrillator, cochlear implant, metal clip
Pregnancy
Simultaneous participation to another interventionnal study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ghina HARIKA-GERMANEAU, Dr
Phone
0033 5 16 52 61 18
Email
ghina.harika-germaneau@ch-poitiers.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ghina HARIKA-GERMANEAU, Dr
Organizational Affiliation
Centre Hospitalier Henri Laborit
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Hospitalier Henri Laborit
City
Poitiers
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ghina Harika-Germaneau, MD, PhD
12. IPD Sharing Statement
Learn more about this trial
Effects of a Classic High-frequency rTMS Treatment Versus a Deep rTMS Treatment
We'll reach out to this number within 24 hrs